Literature DB >> 31183181

Treatment strategy and decision-making for elderly surgical candidates with early lung cancer.

Jiro Okami1.   

Abstract

Among elderly cancer patients of the same chronological age, there is a wide range of heterogeneity in their ability to tolerate surgery. When an elderly patient comes to a thoracic surgeon, the surgeon first considers how healthy the patient is. If the patient looks healthy or in fit condition, the surgeon offers lobectomy plus mediastinal lymph node dissection. On the other hand, if the patient looks frail, the surgeon may offer, instead of a standard treatment, lobectomy without lymph node dissection, sublobar resection, or radiotherapy or may not offer any kind of treatment. This review was conducted to obtain an overview of these options and compare the treatment outcomes reported in the literature for the purpose of making a good decision for elderly surgical candidates with early lung cancer.

Entities:  

Keywords:  Elderly; decision-making; lung cancer; radiotherapy; surgery; treatment strategy

Year:  2019        PMID: 31183181      PMCID: PMC6535475          DOI: 10.21037/jtd.2019.04.01

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  52 in total

1.  Quality of life in the elderly after major lung resection for lung cancer.

Authors:  Michele Salati; Alessandro Brunelli; Francesco Xiumè; Majed Refai; Armando Sabbatini
Journal:  Interact Cardiovasc Thorac Surg       Date:  2008-10-20

2.  Quality of life outcomes are equivalent after lobectomy in the elderly.

Authors:  William R Burfeind; Betty C Tong; Erin O'Branski; James E Herndon; Eric M Toloza; Thomas A D'Amico; Linda H Harpole; David H Harpole
Journal:  J Thorac Cardiovasc Surg       Date:  2008-09       Impact factor: 5.209

3.  Patterns of surgical care of lung cancer patients.

Authors:  Alex G Little; Valerie W Rusch; James A Bonner; Laurie E Gaspar; Mark R Green; W Richard Webb; Andrew K Stewart
Journal:  Ann Thorac Surg       Date:  2005-12       Impact factor: 4.330

4.  Patient preferences regarding possible outcomes of lung resection: what outcomes should preoperative evaluations target?

Authors:  S Cykert; G Kissling; C J Hansen
Journal:  Chest       Date:  2000-06       Impact factor: 9.410

5.  Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database.

Authors:  Carlos M Mery; Anastasia N Pappas; Raphael Bueno; Yolonda L Colson; Philip Linden; David J Sugarbaker; Michael T Jaklitsch
Journal:  Chest       Date:  2005-07       Impact factor: 9.410

6.  Survival in untreated early stage non-small cell lung cancer.

Authors:  Amandeep S Chadha; Apar Kishor Ganti; Jaideep S Sohi; Abe E Sahmoun; Syed A Mehdi
Journal:  Anticancer Res       Date:  2005 Sep-Oct       Impact factor: 2.480

7.  Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer.

Authors:  Rodrigo Arriagada; Bengt Bergman; Ariane Dunant; Thierry Le Chevalier; Jean-Pierre Pignon; Johan Vansteenkiste
Journal:  N Engl J Med       Date:  2004-01-22       Impact factor: 91.245

8.  Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database.

Authors:  Taofeek K Owonikoko; Camille C Ragin; Chandra P Belani; Ana B Oton; William E Gooding; Emanuela Taioli; Suresh S Ramalingam
Journal:  J Clin Oncol       Date:  2007-12-10       Impact factor: 44.544

9.  Worsened long-term outcomes and postoperative complications in octogenarians with lung cancer following mediastinal lymph-node dissection.

Authors:  Masayuki Chida; Muneo Minowa; Yoko Karube; Syunsuke Eba; Yoshinori Okada; Shinichiro Miyoshi; Takashi Kondo
Journal:  Interact Cardiovasc Thorac Surg       Date:  2008-10-23

10.  Natural history of stage I non-small cell lung cancer: implications for early detection.

Authors:  Dan J Raz; Jason A Zell; S-H Ignatius Ou; David R Gandara; Hoda Anton-Culver; David M Jablons
Journal:  Chest       Date:  2007-05-15       Impact factor: 9.410

View more
  6 in total

1.  Prediction of micropapillary and solid pattern in lung adenocarcinoma using radiomic values extracted from near-pure histopathological subtypes.

Authors:  Li-Wei Chen; Shun-Mao Yang; Hao-Jen Wang; Yi-Chang Chen; Mong-Wei Lin; Min-Shu Hsieh; Hsiang-Lin Song; Huan-Jang Ko; Chung-Ming Chen; Yeun-Chung Chang
Journal:  Eur Radiol       Date:  2021-01-03       Impact factor: 5.315

2.  Solid Attenuation Components Attention Deep Learning Model to Predict Micropapillary and Solid Patterns in Lung Adenocarcinomas on Computed Tomography.

Authors:  Li-Wei Chen; Shun-Mao Yang; Ching-Chia Chuang; Hao-Jen Wang; Yi-Chang Chen; Mong-Wei Lin; Min-Shu Hsieh; Mara B Antonoff; Yeun-Chung Chang; Carol C Wu; Tinsu Pan; Chung-Ming Chen
Journal:  Ann Surg Oncol       Date:  2022-07-05       Impact factor: 4.339

3.  Non-Intubated Versus Intubated Video-Assisted Thoracic Surgery in Patients Aged 75 Years and Older: A Propensity Matching Study.

Authors:  Pei-Hsing Chen; Jen-Hao Chuang; Tzu-Pin Lu; Wan-Ting Hung; Hsien-Chi Liao; Tung-Ming Tsai; Mong-Wei Lin; Ke-Cheng Chen; Hsao-Hsun Hsu; Jin-Shing Chen
Journal:  Front Surg       Date:  2022-05-02

Review 4.  A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 3: systematic review of evidence regarding surgery in compromised patients or specific tumors.

Authors:  Brett C Bade; Justin D Blasberg; Vincent J Mase; Ulas Kumbasar; Andrew X Li; Henry S Park; Roy H Decker; David C Madoff; Whitney S Brandt; Gavitt A Woodard; Frank C Detterbeck
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

5.  RAC1 Involves in the Radioresistance by Mediating Epithelial-Mesenchymal Transition in Lung Cancer.

Authors:  Shiming Tan; Pin Yi; Heran Wang; Longzheng Xia; Yaqian Han; Hui Wang; Biao Zeng; Lu Tang; Qing Pan; Yutong Tian; Shan Rao; Linda Oyang; Jiaxin Liang; Jinguan Lin; Min Su; Yingrui Shi; Qianjin Liao; Yujuan Zhou
Journal:  Front Oncol       Date:  2020-04-28       Impact factor: 6.244

6.  Impact of pre-treatment C-reactive protein level and skeletal muscle mass on outcomes after stereotactic body radiotherapy for T1N0M0 non-small cell lung cancer: a supplementary analysis of the Japan Clinical Oncology Group study JCOG0403.

Authors:  Yukinori Matsuo; Yasushi Nagata; Masashi Wakabayashi; Satoshi Ishikura; Hiroshi Onishi; Masaki Kokubo; Katsuyuki Karasawa; Yoshiyuki Shioyama; Rikiya Onimaru; Masahiro Hiraoka
Journal:  J Radiat Res       Date:  2021-09-13       Impact factor: 2.724

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.